Sharp-eyed grocery shoppers may notice new labels in the dairy aisle touting yogurt as way to reduce the risk of Type 2 diabetes. That’s because the U.S. Food and Drug Administration recently said it’s OK for producers of yogurt to make that claim — even though the agency...
Rapidly climbing sales of the new obesity drug Zepbound and its counterpart for diabetes, Mounjaro, pushed Eli Lilly to a better-than-expected first-quarter profit. The drugmaker also hiked its sales and earnings forecast for 2024 beyond Wall Street's expectations even as it hustles...